LIF epigenetically blocks the chemokine MIG (CXCL9), which is involved in the polarization of macrophages along the M1 pathway and ensures the recruitment of cytotoxic CD8+ T cells into the tumor, which have an antitumor effect; hence, a decrease in the level of LIF causes tumor regression [48]. The gene discussed is LIF; the disease is neoplasm.